Background
Patients referred to public orthopaedic clinics can experience long waiting times before assessment. This study aims to evaluate the effectiveness of a collaborative Shoulder/Elbow Triage and Assessment (SHELTA) model of care involving orthopaedic surgeons and physiotherapists to reduce the waitlist and improve service and clinical outcomes for patients on an orthopaedic shoulder/elbow clinic waitlist.
Methods
Patients on the waitlist were triaged by surgeons and physiotherapists and invited to an assessment by experienced physiotherapists. Patients were treated nonoperatively or transferred to orthopaedic management based on clinical discussion. The primary outcome was the number of patients on the waitlist. Secondary outcomes included adverse events, patient satisfaction, re‐referral and conversion to surgery rates. Pain, function and patient global impression of change were recorded for participants managed nonoperatively.
Results
From July 2019 to December 2019, the waitlist reduced from 451 to 298 patients with no adverse events. Seventy‐nine patients could not be contacted and 25 no longer required assessment, and were removed from the waitlist. Nonoperatively managed participants reported satisfaction with the service, a median score of 6 on a 7‐point Patient Global Impression of Change scale, change in pain of −2.5/10 (95% CI −3.3, −1.7; P < 0.001) on a numerical pain rating scale, and change in function of −17.4/100 (95% CI: −24.1, −10.8; P < 0.001) on the QuickDASH, indicating improvement.
Conclusions
The SHELTA model of care effectively reduced the number of patients on an orthopaedic shoulder/elbow clinic waitlist with good service and clinical outcomes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.